RU2010147652A - Способы производства поликлонального белка - Google Patents
Способы производства поликлонального белка Download PDFInfo
- Publication number
- RU2010147652A RU2010147652A RU2010147652/10A RU2010147652A RU2010147652A RU 2010147652 A RU2010147652 A RU 2010147652A RU 2010147652/10 A RU2010147652/10 A RU 2010147652/10A RU 2010147652 A RU2010147652 A RU 2010147652A RU 2010147652 A RU2010147652 A RU 2010147652A
- Authority
- RU
- Russia
- Prior art keywords
- cells
- protein
- elements
- polyclonal
- populations
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract 42
- 108090000623 proteins and genes Proteins 0.000 title claims abstract 42
- 238000000034 method Methods 0.000 title claims abstract 36
- 238000004519 manufacturing process Methods 0.000 claims abstract 10
- 238000000746 purification Methods 0.000 claims abstract 7
- 239000003814 drug Substances 0.000 claims abstract 6
- 238000011081 inoculation Methods 0.000 claims abstract 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 6
- 229940127557 pharmaceutical product Drugs 0.000 claims abstract 5
- 230000010261 cell growth Effects 0.000 claims abstract 2
- 238000012258 culturing Methods 0.000 claims abstract 2
- 230000012010 growth Effects 0.000 claims abstract 2
- 239000001963 growth medium Substances 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- 238000010899 nucleation Methods 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims 36
- 210000003527 eukaryotic cell Anatomy 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 2
- 230000013595 glycosylation Effects 0.000 claims 2
- 238000006206 glycosylation reaction Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4738908P | 2008-04-23 | 2008-04-23 | |
| US61/047,389 | 2008-04-23 | ||
| DKPA200800580 | 2008-04-23 | ||
| DKPA200800580 | 2008-04-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010147652A true RU2010147652A (ru) | 2012-05-27 |
Family
ID=40091979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010147652/10A RU2010147652A (ru) | 2008-04-23 | 2009-04-23 | Способы производства поликлонального белка |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110117605A1 (enExample) |
| EP (1) | EP2280998A1 (enExample) |
| JP (1) | JP2011518790A (enExample) |
| KR (1) | KR20110016899A (enExample) |
| CN (1) | CN102007146A (enExample) |
| AU (1) | AU2009240386A1 (enExample) |
| BR (1) | BRPI0910454A2 (enExample) |
| CA (1) | CA2722348A1 (enExample) |
| IL (1) | IL208163A0 (enExample) |
| MX (1) | MX2010011293A (enExample) |
| NZ (1) | NZ588651A (enExample) |
| RU (1) | RU2010147652A (enExample) |
| SG (1) | SG189793A1 (enExample) |
| WO (1) | WO2009129814A1 (enExample) |
| ZA (1) | ZA201006765B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011001930A (es) * | 2008-08-29 | 2011-04-21 | Symphogen As | Metodo para clonar anticuerpos derivados de aves. |
| ES2692379T3 (es) | 2010-11-01 | 2018-12-03 | Symphogen A/S | Anticuerpos anti-HER3 y composiciones |
| CA2817751C (en) | 2010-11-16 | 2019-04-30 | Excelimmune, Inc. | Methods for producing recombinant proteins |
| WO2013164689A2 (en) | 2012-05-02 | 2013-11-07 | Lantto, Johan | Humanized pan-her antibody compositions |
| US20160289633A1 (en) * | 2013-12-20 | 2016-10-06 | Biogen Ma Inc. | Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality |
| WO2016042412A1 (en) | 2014-09-16 | 2016-03-24 | Symphogen A/S | Anti-met antibodies and compositions |
| DE102014220306B3 (de) * | 2014-10-07 | 2015-09-03 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Automatisches Verfahren zur Beobachtung von Zellkulturwachstum |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| JP7031934B2 (ja) | 2016-05-11 | 2022-03-08 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックス |
| EP3455243B1 (en) | 2016-05-11 | 2021-03-24 | Cytiva BioProcess R&D AB | Separation matrix |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| ES2909833T3 (es) | 2016-05-11 | 2022-05-10 | Cytiva Bioprocess R & D Ab | Método de limpieza y/o desinfección de una matriz de separación |
| US11708390B2 (en) | 2016-05-11 | 2023-07-25 | Cytiva Bioprocess R&D Ab | Method of storing a separation matrix |
| US12448411B2 (en) | 2016-09-30 | 2025-10-21 | Cytiva Bioprocess R&D Ab | Separation method |
| CN110621698B (zh) | 2017-04-05 | 2024-04-12 | 法国施维雅药厂 | 靶向pd-1、tim-3及lag-3的组合疗法 |
| WO2019103976A1 (en) * | 2017-11-22 | 2019-05-31 | Culture Biosciences, Inc. | Fermentation automation workcell |
| US12071607B2 (en) * | 2018-06-01 | 2024-08-27 | Lonza Ltd. | Midscale model for organic growth and phasing |
| MA52945A (fr) | 2018-06-22 | 2021-04-28 | Genmab As | Procédé de production d'un mélange contrôlé d'au moins deux anticorps différents |
| WO2024240634A1 (en) | 2023-05-19 | 2024-11-28 | Les Laboratoires Servier | Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof |
| US20250263653A1 (en) * | 2024-02-16 | 2025-08-21 | Lanzatech, Inc. | Methods and apparatus for the production of protein |
| KR102687341B1 (ko) * | 2024-04-09 | 2024-07-23 | 주식회사 휴온스랩 | 온전한 형태의 히알루로니다제의 생산방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1231268T3 (da) * | 1994-01-31 | 2005-11-21 | Univ Boston | Polyklonale antistofbiblioteker |
| EP1283720B1 (en) * | 2000-05-26 | 2007-04-18 | Symphogen A/S | Recombinant or purified polyclonal antibodies for treating allergy |
| US6849259B2 (en) * | 2000-06-16 | 2005-02-01 | Symphogen A/S | Polyclonal antibody composition for treating allergy |
| US6610472B1 (en) * | 2000-10-31 | 2003-08-26 | Genetastix Corporation | Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| EP1337631A2 (en) * | 2000-11-28 | 2003-08-27 | Applied Molecular Evolution, Inc. | Eukaryotic expression libraries based on double lox recombination and methods of use |
| SI1523496T1 (sl) * | 2002-07-18 | 2011-11-30 | Merus B V | Rekombinantno proizvajanje zmesi protiteles |
| CA2512647C (en) * | 2003-01-07 | 2013-10-08 | Symphogen A/S | Method for manufacturing recombinant polyclonal proteins |
| US20060275766A1 (en) * | 2003-01-07 | 2006-12-07 | Haurum John S | Method for manufacturing recombinant polyclonal proteins |
| EP1706079B1 (en) * | 2003-08-14 | 2013-02-20 | ThromboGenics N.V. | Antibodies against factor viii with modified glycosylation in the variable region |
| RU2426795C2 (ru) * | 2004-07-20 | 2011-08-20 | Симфоген А/С | Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии |
| BRPI0513706A (pt) * | 2004-07-20 | 2008-05-13 | Symphogen As | anticorpo policlonal recombinante anti-rhesus d e métodos de produção |
| US7612181B2 (en) * | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| JP2009518320A (ja) * | 2005-12-05 | 2009-05-07 | シュムフォウエン アクティーゼルスカブ | 抗オルトポックスウイルス組換えポリクローナル抗体 |
| TW200846362A (en) * | 2007-02-09 | 2008-12-01 | Symphogen As | A polyclonal antibody product |
| NZ581316A (en) * | 2007-05-25 | 2012-02-24 | Symphogen As | Method for manufacturing a recombinant polyclonal protein |
-
2009
- 2009-04-23 BR BRPI0910454A patent/BRPI0910454A2/pt not_active IP Right Cessation
- 2009-04-23 KR KR1020107026241A patent/KR20110016899A/ko not_active Withdrawn
- 2009-04-23 US US12/989,340 patent/US20110117605A1/en not_active Abandoned
- 2009-04-23 CA CA2722348A patent/CA2722348A1/en not_active Abandoned
- 2009-04-23 WO PCT/DK2009/050094 patent/WO2009129814A1/en not_active Ceased
- 2009-04-23 SG SG2013028964A patent/SG189793A1/en unknown
- 2009-04-23 CN CN2009801131977A patent/CN102007146A/zh active Pending
- 2009-04-23 EP EP09734906A patent/EP2280998A1/en not_active Withdrawn
- 2009-04-23 NZ NZ588651A patent/NZ588651A/en not_active IP Right Cessation
- 2009-04-23 JP JP2011505362A patent/JP2011518790A/ja not_active Withdrawn
- 2009-04-23 RU RU2010147652/10A patent/RU2010147652A/ru not_active Application Discontinuation
- 2009-04-23 MX MX2010011293A patent/MX2010011293A/es active IP Right Grant
- 2009-04-23 AU AU2009240386A patent/AU2009240386A1/en not_active Abandoned
-
2010
- 2010-09-15 IL IL208163A patent/IL208163A0/en unknown
- 2010-09-21 ZA ZA2010/06765A patent/ZA201006765B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102007146A (zh) | 2011-04-06 |
| NZ588651A (en) | 2012-04-27 |
| IL208163A0 (en) | 2010-12-30 |
| MX2010011293A (es) | 2010-12-20 |
| WO2009129814A1 (en) | 2009-10-29 |
| BRPI0910454A2 (pt) | 2018-03-27 |
| ZA201006765B (en) | 2012-03-28 |
| CA2722348A1 (en) | 2009-10-29 |
| EP2280998A1 (en) | 2011-02-09 |
| KR20110016899A (ko) | 2011-02-18 |
| SG189793A1 (en) | 2013-05-31 |
| JP2011518790A (ja) | 2011-06-30 |
| US20110117605A1 (en) | 2011-05-19 |
| AU2009240386A1 (en) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010147652A (ru) | Способы производства поликлонального белка | |
| JP2011518790A5 (enExample) | ||
| RU2008113220A (ru) | Способ получения белков с использованием соединений, препятствующих старению | |
| Fujita | Industrial production of shikonin and berberine | |
| US10711057B2 (en) | Methods of shifting an isoelectric profile of a protein product and uses thereof | |
| CN103080300A (zh) | 增加细胞培养物的产率和活力的二肽 | |
| WO2002101019A3 (en) | Methods of culturing animal cells and polypeptide production in animal cells | |
| CN116716348A (zh) | 一种提高重组细胞的蛋白表达量的方法 | |
| CN102268402A (zh) | 无血清培养基及cho细胞中高效表达促红素的培养方法 | |
| CN103320388B (zh) | 提高抗体表达量和改良糖基化水平的细胞培养方法 | |
| CA1312030C (en) | Method to increase antibody titer | |
| Franěk et al. | 24-Epibrassinolide at subnanomolar concentrations modulates growth and production characteristics of a mouse hybridoma | |
| CN1800368A (zh) | 无血清配方的动物细胞培养基胎牛血清替代剂 | |
| CN104152415B (zh) | 获得高产稳定表达重组抗体的骨髓瘤细胞株的方法及应用 | |
| CN102660505B (zh) | 亚克隆细胞株tf-1-a2及其制备方法与用途 | |
| CN113025648B (zh) | Expi293细胞瞬时表达目标蛋白的方法及其应用 | |
| CN105349592B (zh) | 代谢互补的植物细胞系混种培养生产次级代谢产物的方法 | |
| CN102533721A (zh) | 一种通过渗透压突变提高重组蛋白瞬时表达的方法 | |
| CN119874883B (zh) | 一种用于头皮护理的细胞外基质胶原蛋白及其制备方法与应用 | |
| CN100427590C (zh) | 人胚肾293细胞亚克隆细胞株 | |
| WO2004033673A2 (en) | Production process for plant biomass and its use | |
| KR100426397B1 (ko) | 초기단계의 체세포배성 세포로부터 산삼 부정근의대량생산방법 | |
| EP4183251A1 (en) | Method for obtaining carminic acid | |
| WO2025109545A1 (en) | Methods for producing recombinant proteins | |
| CN1613387A (zh) | 采用工业发酵罐生产高纤椰果的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20130513 |